Table 1 Baseline clinical and CMR characteristics
CA (n = 45) | HCM (n = 19) | p value (vs CA) | AFD (n = 19) | p value (vs CA) | |
|---|---|---|---|---|---|
Age (years) | 66.6 ± 10.0 | 57.0 ± 10.1 | 0.0004 | 49.3 ± 8.8 | <0.0001 |
Sex (%male) | 28 (62%) | 14 (74%) | 0.39 | 13 (68%) | 0.65 |
Hypertension(%) | 17 (38%) | 7 (37%) | 0.99 | 8 (42%) | 0.78 |
ΒSA (m2) | 1.85 ± 0.27 | 1.94 ± 0.21 | 0.17 | 1.92 ± 0.17 | 0.23 |
Heart rate at CMR (bpm) | 76 ± 16 | 65 ± 17 | 0.009 | 65 ± 11 | 0.007 |
LVEF (%) | 53.8 ± 11.2 | 61.6 ± 9.4 | 0.009 | 61.1 ± 6.4 | 0.009 |
LVEDVi (ml/m2) | 80.9 ± 23.8 | 80.1 ± 17.0 | 0.86 | 90.4 ± 18.0 | 0.09 |
LVESVi (ml/m2) | 39.1 ± 19.5 | 34.9 ± 18.5 | 0.46 | 34.9 ± 7.5 | 0.98 |
LVMI (g/m2) | 90.5 ± 30.9 | 89.5 ± 28.8 | 0.98 | 87.2 ± 32.5 | 0.58 |
LV wall thickness basal LV (mm) | 13.4 ± 2.8 | 12.5 ± 2.5 | 0.10 | 11.2 ± 3.0 | 0.004 |
LV wall thickness mid LV (mm) | 11.4 ± 2.5 | 12.3 ± 4.2 | 0.41 | 10.2 ± 8.9 | 0.009 |
LV wall thickness apical LV (mm) | 8.9 ± 2.4 | 9.1 ± 3.1 | 0.83 | 8.9 ± 4.4 | 0.21 |